These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35464420)

  • 1. Genetic Modifiers of Thymic Selection and Central Tolerance in Type 1 Diabetes.
    Kissler S
    Front Immunol; 2022; 13():889856. PubMed ID: 35464420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic architecture of type 1 diabetes mellitus.
    Nyaga DM; Vickers MH; Jefferies C; Perry JK; O'Sullivan JM
    Mol Cell Endocrinol; 2018 Dec; 477():70-80. PubMed ID: 29913182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic B Cell-Mediated Attack of Thymic Stroma Precedes Type 1 Diabetes Development.
    Pinto AI; Smith J; Kissack MR; Hogg KG; Green EA
    Front Immunol; 2018; 9():1281. PubMed ID: 29930554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
    PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in type I diabetes associated tolerance mechanisms.
    Chentoufi AA; Binder NR; Berka N; Abunadi T; Polychronakos C
    Scand J Immunol; 2008 Jul; 68(1):1-11. PubMed ID: 18482207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
    Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk.
    Liu N; Sadlon T; Wong YY; Pederson S; Breen J; Barry SC
    Epigenetics Chromatin; 2022 Jun; 15(1):24. PubMed ID: 35773720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic overlap between type 1 diabetes and other autoimmune diseases.
    Márquez A; Martín J
    Semin Immunopathol; 2022 Jan; 44(1):81-97. PubMed ID: 34595540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Impact of Risk Gene Variants on the Autoimmune Responses in Type 1 Diabetes.
    Gootjes C; Zwaginga JJ; Roep BO; Nikolic T
    Front Immunol; 2022; 13():886736. PubMed ID: 35603161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
    Su M; Lin Y; He Z; Lai L
    Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakdown in peripheral tolerance in type 1 diabetes in mice and humans.
    Jeker LT; Bour-Jordan H; Bluestone JA
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007807. PubMed ID: 22393537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping genes for autoimmunity in humans: type 1 diabetes as a model.
    Onengut-Gumuscu S; Concannon P
    Immunol Rev; 2002 Dec; 190():182-94. PubMed ID: 12493015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide functional genomics approach uncovers genetic determinants of immune phenotypes in type 1 diabetes.
    Chu X; Janssen AWM; Koenen H; Chang L; He X; Joosten I; Stienstra R; Kuijpers Y; Wijmenga C; Xu CJ; Netea MG; Tack CJ; Li Y
    Elife; 2022 May; 11():. PubMed ID: 35638288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific autoimmunity controlled by Aire in thymic and peripheral tolerance mechanisms.
    Matsumoto M; Tsuneyama K; Morimoto J; Hosomichi K; Matsumoto M; Nishijima H
    Int Immunol; 2020 Feb; 32(2):117-131. PubMed ID: 31586207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling.
    Elo LL; Mykkänen J; Nikula T; Järvenpää H; Simell S; Aittokallio T; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O; Lahesmaa R
    J Autoimmun; 2010 Aug; 35(1):70-6. PubMed ID: 20356713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genetic Contribution to Type 1 Diabetes.
    Bakay M; Pandey R; Grant SFA; Hakonarson H
    Curr Diab Rep; 2019 Nov; 19(11):116. PubMed ID: 31686270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes affecting β-cell function in type 1 diabetes.
    Fløyel T; Kaur S; Pociot F
    Curr Diab Rep; 2015 Nov; 15(11):97. PubMed ID: 26391391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic B Cells as a New Player in the Type 1 Diabetes Response.
    Greaves RB; Chen D; Green EA
    Front Immunol; 2021; 12():772017. PubMed ID: 34745148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations.
    Capalbo D; Giardino G; Martino LD; Palamaro L; Romano R; Gallo V; Cirillo E; Salerno M; Pignata C
    Int Rev Immunol; 2012 Oct; 31(5):344-62. PubMed ID: 23083345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.